Document is current

Any future updates will be listed below

Author Correction: Eriodictyol attenuates osteoarthritis progression through inhibiting inflammation via the PI3K/AKT/NF-κB signaling pathway

Crossref DOI link: https://doi.org/10.1038/s41598-024-74713-w

Published Online: 2024-10-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark